Connecticut Children's Becomes Third in Nation to End Pediatric Gender Care Under DOJ Deal
- 2 minutes ago
- 2 min read
On August 5, 2026, the U.S. Department of Justice announced a settlement with Connecticut Children's Medical Center in Hartford ending the hospital's pediatric gender-affirming care program.
Connecticut Children’s becomes the third major system—following Texas Children’s Hospital and the Cleveland Clinic—to reach an agreement with federal authorities amid ongoing nationwide inquiries into pediatric care programs. Under the terms, Connecticut Children's agreed not to administer puberty blockers, cross-sex hormones, or gender-affirming surgeries to minors. The hospital also agreed to pay a civil penalty and designate $500,000 to provide medical care for patients affected by prior treatments.
In a public statement, Connecticut Children's denied all allegations of wrongdoing, emphasizing that the agreement resolved the matter while protecting patient privacy without turning over private medical records to federal investigators.
Federal Gender-Affirming Insurance Claim Investigation
The action at Connecticut Children's coincides with broader oversight by the U.S. Department of Health and Human Services. On August 13, 2026, HHS issued a report titled "Wolves in White Coats," analyzing nationwide insurance claims from 2015 through 2025. The report identified approximately $50 million in insurance claims for puberty blockers billed under broad or unspecific diagnostic codes. Federal officials allege that certain facilities misused billing codes to secure coverage from public and private insurers, referring flagged health systems for further regulatory review.
Connecticut Lawmakers Push Back
Top Connecticut officials strongly criticized the federal actions, arguing that federal pressure undermines access to necessary healthcare.
CT Governor Ned Lamont: Governor Lamont expressed disappointment over federal intervention driving hospital policy changes, noting that such moves do not align with state values or statutory protections. He noted that while major hospitals face federal pressure, residents may still seek services through non-profit community health providers, adding: "To transgender youth and their families in Connecticut: you are not alone. We see you, we support you, and we are working closely with state leaders to understand the full impact."
CT Attorney General William Tong: Attorney General Tong reaffirmed his commitment to enforcing Connecticut’s 2022 legal protections for gender-affirming healthcare, which shield local clinicians operating under state law from out-of-state and federal legal challenges.
Evolving Landscape of Gender-Affirming Care in CT
The agreement reflects a broader shift across Connecticut’s healthcare institutions. Last year, Yale New Haven Health paused medical interventions like puberty blockers and hormone therapy for patients aged 19 and under, while continuing to offer mental health evaluations and care coordination.
With major hospital networks stepping back from medical interventions for youth, pediatric care in the state is increasingly transitioning to independent community clinics—such as Anchor Health Initiative and Planned Parenthood of Southern New England—which continue to operate under state regulatory guidelines.
Between the Lines: Despite state-level legal protections, major hospital systems are realizing that the legal and financial risks of pediatric gender care are too high to bear. The era of Connecticut hospitals providing puberty blockers, cross-sex hormones, and surgical procedures may finally be coming to an end.